Innovation Pharmaceuticals Inc (IPIX)

[To infinity and beyond!]

it would seem the market response to the trial news -loss of 25% of value, and back to recent lows- is exaggerated. Results are certainly fine to move forward with, and the value of brilacidin remains high.

Would the same sell-off occur for better results? Just sell the news, no matter what?

Agree that the science keeps moving forward. Unfortunately must also agree with plenty paranoid that big pharma has more leverage now in bidding rather than less, and this hurts the company in the short run

another concern of course is prurisol. With an unsuccessful trial the short run will be considerably more bleak